Anti-LGI1 mAb: ATTO 565 [S283-7]
產品名稱: Anti-LGI1 mAb: ATTO 565 [S283-7]
英文名稱: LGI1 Monoclonal Antibody: ATTO 565 [S283-7]
產品編號: SMC-461D-A565
產品價格: null
產品產地: 加拿大
品牌商標: StressMarq
更新時間: null
使用范圍: WB, ICC, IHC
StressMarq
- 聯系人 :
- 地址 : 加拿大
- 郵編 :
- 所在區域 : 其他
- 電話 : 138****6620; 點擊查看
- 傳真 : 點擊查看
- 郵箱 : hedyl@stressmarq.com
The leucine-rich, glioma inactivated gene 1 (LGI1) was first identified as a candidate tumor suppressor gene for glioma and may play a role in other cancers. LGI1 is a member of a family of highly related proteins containing leucine-rich repeats (LRRs) which are highly similar to other transmembrane signaling molecules and receptors. LGI1 serves as a ligand to ADAM22, a metalloprotease localized at the synapse. Mutations in LGI1 account for nearly half of autodominant lateral temporal epilepsy (ADTLE), an epileptic syndrome characterized by focal seizures with predominant auditory symptoms. Two isoforms of LGI1 are known to exist; this LGI1 antibody will recognize only the longer form.
